These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6411138)

  • 21. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
    Buters JT; Reichen J
    Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Harder M; Egberts EH
    Eur J Clin Pharmacol; 1982; 21(6):521-8. PubMed ID: 6804246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of short-term water deprivation on antipyrine disposition.
    Prasad P; Jung D; Niazi S
    J Pharm Sci; 1985 Mar; 74(3):338-9. PubMed ID: 4009446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of formaldehyde by N-demethylation of antipyrine. Detection of formaldehyde in bile by 13C-NMR spectroscopy.
    Huetter P; Albert K; Bayer E; Zeller KP; Hartmann F
    Biochem Pharmacol; 1987 Sep; 36(17):2729-33. PubMed ID: 3632703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation and urinary pattern of 4,4'-dihydroxy-antipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and rat.
    Böttcher J; Bässmann H; Schüppel R
    J Pharm Pharmacol; 1982 Mar; 34(3):168-75. PubMed ID: 6121894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
    Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
    Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Rhodes JC; Houston JB
    Drug Metab Dispos; 1983; 11(2):131-6. PubMed ID: 6133717
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose dependent suppression of hepatic cytochrome P-450 content by doxorubicin and Mitomycin-C: correlation with antipyrine biotransformation.
    Wissel PS
    Life Sci; 1988; 42(11):1139-45. PubMed ID: 3126372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
    Uchino H; Inaba T; Kalow W
    Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminopyrine demethylation kinetics. Use of metabolite exhalation rates as an index of enhanced mixed-function oxidase activity in vivo.
    Houston JB; Lockwood GF; Taylor G
    Drug Metab Dispos; 1981; 9(5):449-55. PubMed ID: 6117444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.
    Thornhill DP; Steffen C; Netter KJ
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):161-8. PubMed ID: 6430705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat.
    White SM; Allen JG; Altman JF
    Xenobiotica; 1987 Jul; 17(7):869-73. PubMed ID: 3660856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.